Drug profile · INN
reserpine
RESERPINE
reserpine (RESERPINE) is a synaptic vesicular amine transporter inhibitor. Associated with BICYCLE THERAPEUTICS. Route of administration: injection. Current US regulatory status: approved.
Drug details — reserpine
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
reserpine (RESERPINE) is a synaptic vesicular amine transporter inhibitor. Associated with BICYCLE THERAPEUTICS. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Synaptic vesicular amine transporter inhibitor
Primary target: Synaptic vesicular amine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is reserpine?
reserpine (RESERPINE) is a synaptic vesicular amine transporter inhibitor. Associated with BICYCLE THERAPEUTICS. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for reserpine?
RESERPINE is a marketed brand name for reserpine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of reserpine?
reserpine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.